Balzer Felix, Aronson Solomon, Campagna Jason A, Ding Li, Treskatsch Sascha, Spies Claudia, Sander Michael
Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Department of Anesthesiology, Duke University, Durham, NC.
J Cardiothorac Vasc Anesth. 2016 Dec;30(6):1562-1570. doi: 10.1053/j.jvca.2016.05.040. Epub 2016 May 25.
Gaps and uncertainty exist regarding the understanding of optimal clinical goals for perioperative (ie, preoperative, intraoperative, and postoperative) blood pressure (BP) management in patients undergoing cardiac surgery and the consequences of achieving or failing to achieve those goals. In this setting, it is understood that preoperative hypertension is predictive of poor postoperative outcomes, with a growing appreciation that current, clinically acceptable changes in intraoperative BP also may be associated independently with adverse short- and long-term outcomes. In contrast, the impact of postoperative BP on outcomes after cardiac surgery remains less clear.
This study was a retrospective outcome analysis.
The study included all cardiac surgery patients cared for at a single institution over a 7-year period. Consequences of the success or failure of meeting postoperative BP targets on medical outcomes and health resource utilization were evaluated.
The study comprised 5,225 patients. Hypertensive postoperative patients experienced a higher in-hospital mortality rate compared with matched-case normotensive patients (4.97% v 1.32%, p<0.001) and a longer hospital stay (p = 0.024). In hypertensive patients, serum creatinine levels from postoperative day 1 through postoperative day 7 were increased compared with baseline and postoperative renal dysfunction according to the Kidney Disease: Improving Global Outcomes criteria occurred significantly more often (25.3% v 19.7%, p = 0.027).
Postoperative hypertension is associated with compromised outcome as reflected by higher mortality, longer length of stay, and higher incidence of renal dysfunction.
在心脏手术患者围手术期(即术前、术中和术后)血压(BP)管理的最佳临床目标的理解以及实现或未实现这些目标的后果方面,存在差距和不确定性。在这种情况下,据了解术前高血压可预测术后不良结局,并且越来越多的人认识到术中血压目前临床上可接受的变化也可能独立地与不良的短期和长期结局相关。相比之下,术后血压对心脏手术后结局的影响仍不太清楚。
本研究为回顾性结局分析。
该研究纳入了一家机构在7年期间治疗的所有心脏手术患者。评估了达到或未达到术后血压目标对医疗结局和卫生资源利用的影响。
该研究包括5225名患者。与匹配的血压正常患者相比,术后高血压患者的院内死亡率更高(4.97%对1.32%,p<0.001),住院时间更长(p = 0.024)。在高血压患者中,术后第1天至术后第7天的血清肌酐水平较基线升高,并且根据改善全球肾脏病预后组织(Kidney Disease: Improving Global Outcomes)标准,术后肾功能不全的发生率显著更高(25.3%对19.7%,p = 0.027)。
术后高血压与死亡率升高、住院时间延长和肾功能不全发生率更高所反映的结局受损相关。